Skip to content
Shagandha®
  • About Shagandha®
    • Introduction
    • Traditional Significance
    • Chemistry
    • Why Shagandha®?
      • Complies with USP monograph
      • NON-GMO Project Verified
    • Benefits
  • Research
    • Preclinical
    • Clinical
    • Publications
  • IP Rights
    • Patents
    • Trademark Licence
  • About Sabinsa
    • Newsroom
      • Press Releases
      • Shagandha® Book
      • Ads
      • FAQs
  • Contact Us

Sami-Sabinsa Group FSMA Implementation Update: 14 Staff PCQI Certified

The Sami–Sabinsa Group now has a total of 14 staff members specifically trained in implementing the 21 CFR part 117 regulations, covering all of the company’s manufacturing facilities. Recently 13 staff members in India were trained per the Food Safety Preventive Control Alliance (FSPCA) by UL, the independent safety science organization, as Preventive Control Qualified Individuals (PCQI). There has been a trained PCQI officer in the Payson, Utah plant to comply with the Food Safety Modernization Act (FSMA) since July 2017.

“The changes required by FSMA, the most far-reaching overhaul of food regulation in the US since 1938’s Food, Drug and Cosmetics Act, make it absolutely necessary for many departments to work more closely together to implement the requirements,” said Dr. Muhammed Majeed, founder of Sabinsa. “For example, Purchase/Procurement teams, Phyto Identification teams, IT, and HR departments all have their roles carved out in implementing FSMA regulations because of the complex components. As an additional benefit to our continual quality improvement initiatives, this PCQI training helps Sabinsa to implement practices and procedures that minimizes the risk of contamination or other product safety issues and, thus, help to reduce the risk of regulatory and consumer actions in the first place.”

The FSPCA training UL provided to Sabinsa was geared specifically to the dietary supplements industry, rather than the more general food manufacturing industry. The training is wide-ranging, covering both best practices and specific preventive control measures such as allergen controls, hazard identification and preventive controls, and supply chain program management. In addition, attention is focused on microbiological testing, procedures for receiving incoming material, handling of finished formulations, and the potential biological hazards that can cause foodborne illness.

“Through our training and advisory services, UL is proud to have assisted Sabinsa to meet the requirements for PCQI through training,” said Chris Aiyer, Senior Sales Executive, UL.

Sabinsa sells ingredients across the globe and follows the regulatory requirements in each country in which it does business. For meeting US-specific regulatory requirements, US FDA has inspected multiple Sami Labs facilities including the Nelamangala biotech plant and the Super Critical Fluid Extract (SCFE) facility under the FSVP (Foreign Supplier Verification Program). The Kunigal facility, which hosts the largest herbal extraction capabilities for the Sami-Sabinsa Group, underwent another routine US FDA inspection earlier this year.

About UL:

UL is a premier global independent safety science company that has championed progress for 120 years. Its more than 10,000 professionals are guided by the UL mission to promote safe working and living environments for all people. UL uses research and standards to continually advance and meet ever-evolving safety needs. UL partners with businesses, manufacturers, trade associations and international regulatory authorities to bring solutions to a more complex global supply chain. For more information about UL certification, testing, inspection, advisory and education services, visit ul.com

Back

About Sabinsa

Sabinsa is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.

Read More..

Headquarters

Sabinsa Corporation

20 Lake Drive 

East Windsor

NJ 08520, USA

 

Tel : +1 732 777 1111

Fax: +1 732 777 1443

info@sabinsa.com

Global Contact List

USAIndia
Utah, USAJapan
AustraliaPoland
BrasilKorea
CanadaSouth Africa
ChinaVietnam
Germany 

Contact us

    © 2025 Sabinsa. All Rights Reserved | Privacy Policy | Sitemap | Terms of Use | Disclaimer

    ×

    Disclaimer

    US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

    EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.